Skip to main content
SpringerLink
Log in

Forecasting early onset diminished ovarian reserve for young reproductive age women

  • Reproductive Physiology and Disease
  • Published:
Journal of Assisted Reproduction and Genetics Aims and scope Submit manuscript

Abstract

Purpose

To investigate the biological networks associated with DOR in young women and the subsequent molecular impact on preimplantation embryos.

Methods

Whole peripheral blood was collected from patients: young women presenting with diminished ovarian reserve (DOR) and age-matched young women with normal ovarian reserve. Maternal exome sequencing was performed on the NovaSEQ 6000 and sequencing validation was completed using Taqman® SNP Genotyping Assays. Blastocyst global methylome and transcriptome sequencing were also analyzed.

Results

Exome sequencing revealed 730 significant DNA variants observed exclusively in the young DOR patients. Bioinformatic analysis revealed a significant impact to the Glucocorticoid receptor (GR) signaling pathway and each young DOR female had an average of 6.2 deleterious DNA variants within this pathway. Additional stratification based on patient age resulted in a cut-off at 31 years for young DOR discrimination. Embryonic global methylome sequencing resulted in only a very small number of total CpG sites with methylation alterations (1,775; 0.015% of total) in the DOR group. Additionally, there was no co-localization between these limited number of altered CpG sites and significant variants, genes, or pathways. RNA sequencing also resulted in no biologically significant transcription changes between DOR blastocysts and controls.

Conclusion

GR signaling DNA variants were observed in women with early-onset DOR potentially compromising oocyte production and quality. However, no significant downstream effects on biological processes appear to impact the resulting blastocyst. The ability to forecast premature DOR for young women may allow for earlier identification and clinical intervention for this patient population.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Broekmans FJ, Knauff EAH, te Velde ER, Macklon NS, Fauser BC. Female reproductive ageing: current knowledge and future trends. Trends Endocrinol Metab. 2007;18(2):58–65.

    Article  CAS  Google Scholar 

  2. Broekmans FJ, Soules MR, Fauser BC. Ovarian aging: mechanisms and clinical consequences. Endocr Rev. 2009;30(5):465–93.

    Article  CAS  Google Scholar 

  3. Nikolaou D, Templeton A. Early ovarian ageing: a hypothesis. Detection and clinical relevance. Hum Reprod. 2003;18(6):1137–9.

    Article  CAS  Google Scholar 

  4. Gleicher N, Weghofer A, Oktay K, Barad D. Relevance of triple CGG repeats in the FMR1 gene to ovarian reserve. Reprod BioMed Online. 2009;19(3):385–90.

    Article  CAS  Google Scholar 

  5. Wang TT, Ke ZH, Song Y, Chen LT, Chen XJ, Feng C, et al. Identification of a mutation in GDF9 as a novel cause of diminished ovarian reserve in young women. Hum Reprod. 2013;28(9):2473–81.

    Article  CAS  Google Scholar 

  6. Warman DM, Costanzo M, Marino R, Berensztein E, Galeano J, Ramirez PC, et al. Three new SF-1 (NR5A1) gene mutations in two unrelated families with multiple affected members: within-family variability in 46, XY subjects and low ovarian reserve in fertile 46, XX subjects. Horm Res Paediatr. 2011;75(1):70–7.

    Article  CAS  Google Scholar 

  7. Nelson LM. Clinical practice. Primary ovarian insufficiency. N Engl J Med. 2009;360(6):606–14.

    Article  CAS  Google Scholar 

  8. Ata B, Seyhan A, Seli E. Diminished ovarian reserve versus ovarian aging: overlaps and differences. Curr Opin Obstet Gynecol. 2019;31(3):139–47.

    Article  Google Scholar 

  9. Oudendijk JF, Yarde F, Eijkemans MJC, Broekmans FJM, Broer SL. The poor responder in IVF: is the prognosis always poor?: a systematic review. Hum Reprod Update. 2012;18(1):1–11.

    Article  CAS  Google Scholar 

  10. Zhao H, Qin Y, Kovanci E, Simpson JL, Chen ZJ, Rajkovic A. Analyses of GDF9 mutation in 100 Chinese women with premature ovarian failure. Fertil Steril. 2007;88(5):1474–6.

    Article  Google Scholar 

  11. Wang TT, Wu YT, Dong MY, Sheng JZ, Leung PCK, Huang HF. G546A polymorphism of growth differentiation factor-9 contributes to the poor outcome of ovarian stimulation in women with diminished ovarian reserve. Fertil Steril. 2010;94(6):2490–2.

    Article  CAS  Google Scholar 

  12. Laissue P, Christin-Maitre S, Touraine P, Kuttenn F, Ritvos O, Aittomaki K, et al. Mutations and sequence variants in GDF9 and BMP15 in patients with premature ovarian failure. Eur J Endocrinol. 2006;154(5):739–44.

    Article  CAS  Google Scholar 

  13. De Conto E, et al. Endometriosis-associated infertility: GDF-9, AMH, and AMHR2 genes polymorphisms. J Assist Reprod Genet. 2017;34(12):1667–72.

    Article  Google Scholar 

  14. Eslami H, Eslami A, Favaedi R, Asadpour U, Zari Moradi S, Eftekhari-Yazdi P, et al. Epigenetic aberration of FMR1 gene in infertile women with diminished ovarian reserve. Cell J. 2018;20(1):78–83.

    PubMed  PubMed Central  Google Scholar 

  15. Tang R, Yu Q. Novel variants in women with premature ovarian function decline identified via whole-exome sequencing. J Assist Reprod Genet. 2020;37(10):2487–502.

    Article  Google Scholar 

  16. Denomme MM, McCallie BR, Parks JC, Booher K, Schoolcraft WB, Katz-Jaffe MG. Inheritance of epigenetic dysregulation from male factor infertility has a direct impact on reproductive potential. Fertil Steril. 2018;110(3):419–28. e1.

    Article  Google Scholar 

  17. Baschant U, Tuckermann J. The role of the glucocorticoid receptor in inflammation and immunity. J Steroid Biochem Mol Biol. 2010;120(2-3):69–75.

    Article  CAS  Google Scholar 

  18. Heitzer MD, Wolf IM, Sanchez ER, Witchel SF, DeFranco DB. Glucocorticoid receptor physiology. Rev Endocr Metab Disord. 2007;8(4):321–30.

    Article  CAS  Google Scholar 

  19. Hefler LA, Gregg AR. Influence of the angiotensinogen gene on the ovulatory capacity of mice. Fertil Steril. 2001;75(6):1206–11.

    Article  CAS  Google Scholar 

  20. Ricciardelli C, Lokman NA, Pyragius CE, Ween MP, Macpherson AM, Ruszkiewicz A, et al. Keratin 5 overexpression is associated with serous ovarian cancer recurrence and chemotherapy resistance. Oncotarget. 2017;8(11):17819–32.

    Article  Google Scholar 

  21. Virant-Klun I, et al. Ovarian surface epithelium in patients with severe ovarian infertility: a potential source of cells expressing markers of pluripotent/multipotent stem cells. J Biomed Biotechnol. 2011;2011:381928.

    Article  Google Scholar 

  22. Wang P-H. Role of sex hormone receptors in ovulation. Taiwan J Obstet Gynecol. 2005;44(1):16–25.

    Article  Google Scholar 

  23. Ribeiro JR, et al. Targeting TBP-associated factors in ovarian cancer. Front Oncol. 2014;4:45.

    Article  Google Scholar 

  24. Di Pietro C, et al. Expression analysis of TFIID in single human oocytes: new potential molecular markers of oocyte quality. Reprod BioMed Online. 2008;17(3):338–49.

    Article  Google Scholar 

  25. Ziv-Gal A, Gao L, Karman BN, Flaws JA. In vitro re-expression of the aryl hydrocarbon receptor (Ahr) in cultured Ahr-deficient mouse antral follicles partially restores the phenotype to that of cultured wild-type mouse follicles. Toxicol in Vitro. 2015;29(2):329–36.

    Article  CAS  Google Scholar 

  26. Luborsky J, Barua A, Edassery S, Bahr JM, Edassery SL. Inflammasome expression is higher in ovarian tumors than in normal ovary. PLoS One. 2020;15(1):e0227081.

    Article  CAS  Google Scholar 

  27. Jackson PK. Regulating microtubules and genome stability via the CUL7/3M syndrome complex and CUL9. Mol Cell. 2014;54(5):713–5.

    Article  CAS  Google Scholar 

  28. Monget P, Fabre S, Mulsant P, Lecerf F, Elsen JM, Mazerbourg S, et al. Regulation of ovarian folliculogenesis by IGF and BMP system in domestic animals. Domest Anim Endocrinol. 2002;23(1-2):139–54.

    Article  CAS  Google Scholar 

  29. Wang H, Rosen DG, Wang H, Fuller GN, Zhang W, Liu J. Insulin-like growth factor-binding protein 2 and 5 are differentially regulated in ovarian cancer of different histologic types. Mod Pathol. 2006;19(9):1149–56.

    Article  CAS  Google Scholar 

  30. Malcuit C, Trask MC, Santiago L, Beaudoin E, Tremblay KD, Mager J. Identification of novel oocyte and granulosa cell markers. Gene Expr Patterns. 2009;9(6):404–10.

    Article  CAS  Google Scholar 

  31. Knauff EA, Blauw HM, Pearson PL, Kok K, Wijmenga C, Veldink JH, et al. Copy number variants on the X chromosome in women with primary ovarian insufficiency. Fertil Steril. 2011;95(5):1584–8. e1.

    Article  CAS  Google Scholar 

  32. Zhang M, Liu T, Xia B, Yang C, Hou S, Xie W, et al. Platelet-derived growth factor D is a pognostic biomarker and is associated with platinum resistance in epithelial ovarian cancer. Int J Gynecol Cancer. 2018;28(2):323–31.

    Article  CAS  Google Scholar 

  33. Chang Y, Li J, Li X, Liu H’, Liang X. Egg quality and pregnancy outcome in young infertile women with diminished ovarian reserve. Med Sci Monit. 2018;24:7279–84.

    Article  CAS  Google Scholar 

  34. Bishop LA, Richter KS, Patounakis G, Andriani L, Moon K, Devine K. Diminished ovarian reserve as measured by means of baseline follicle-stimulating hormone and antral follicle count is not associated with pregnancy loss in younger in vitro fertilization patients. Fertil Steril. 2017;108(6):980–7.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Colorado Center for Reproductive Medicine, Lone Tree, Colorado, 80124, USA

    Blair R. McCallie, Mary Haywood, Michelle M. Denomme, Rachel Makloski, Jason C. Parks, William B. Schoolcraft & Mandy G. Katz-Jaffe

  2. School of Biosciences, University of Kent, Canterbury, CT2 7NJ, UK

    Blair R. McCallie, Jason C. Parks & Darren K. Griffin

Authors
  1. Blair R. McCallie
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mary Haywood
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Michelle M. Denomme
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Rachel Makloski
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jason C. Parks
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Darren K. Griffin
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. William B. Schoolcraft
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Mandy G. Katz-Jaffe
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Blair R. McCallie.

Ethics declarations

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

ESM 1

(XLSX 397 kb)

ESM 2

(XLSX 11 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

McCallie, B.R., Haywood, M., Denomme, M.M. et al. Forecasting early onset diminished ovarian reserve for young reproductive age women. J Assist Reprod Genet 38, 1853–1860 (2021). https://doi.org/10.1007/s10815-021-02155-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10815-021-02155-8

Keywords

Search

Navigation